Previously undiscovered cannibis compound could lead to improved epilepsy treatment

September 13, 2012

(Medical Xpress)—Scientists at the University of Reading have demonstrated for the first time that a previously unstudied chemical in cannabis could lead to more effective treatments for people with epilepsy.

The team at the University's Department of Pharmacy and School of Psychology have discovered that cannabidivarin (CBDV) - a largely ignored found in cannabis - has the potential to prevent more seizures, with few side effects such as uncontrollable shaking, caused by many existing anti-epileptic drugs.

In the study, carried out by the University of Reading in collaboration with GW Pharma and Otsuka Pharmaceuticals, cannabidivarin strongly suppressed seizures in six different commonly used in epilepsy .

Cannabidivarin was also found to work when combined with drugs currently used to control epilepsy and, unlike other cannabinoids (unique components in cannabis) such as THC, is not psychoactive and therefore does not cause users to feel 'high'.

The video will load shortly
Dr Ben Whalley talking about the discovery.

The findings are reported in the journal.

Dr Ben Whalley is leading the study at the University of Reading alongside colleagues Dr Gary Stephens and Dr Claire Williams.

Dr Whalley said: "This is an enormously exciting milestone in our investigations into non-psychoactive elements of cannabis as treatments for epilepsy.

"There is a pressing need for better treatments for epilepsy. It's a with no cure and currently in around one third of cases, the currently available treatments do not work, cause serious side-effects and increase fatalities. Currently prescribed drugs to prevent fits can cause significant side-effects to individuals' motion and that can adversely affect the quality of life for people who have to take them every day.

"Our work has highlighted the potential for a solution based on cannabinoid science.  It has shown that cannabidivarin is the most effective and best tolerated anticonvulsant plant cannabinoid investigated to date."

Dr Stephen Wright, R&D director at GW Pharmaceuticals said: "These results further underscore the potential of naturally-derived cannabinoids as medicines to treat a broad range of diseases. GW has established a track record of discovering and commercialising such compounds with Sativex now on the market for treating spasticity associated with multiple sclerosis and in late stage development for the treatment of cancer pain. Our research into CBDV has consistently produced highly promising results demonstrating its potential as a novel anticonvulsant and GW hopes during 2013 to advance CBDV into human clinical trials."

Following the discovery, scientists at Reading are investigating the mechanisms by which cannabidivarin works to reduce seizures and are testing CBDV in chronic models of epilepsy that closely mimic the clinical condition. This work will be completed by the end of 2012.

affects approximately 1% of people worldwide, and is caused by excessive electrical activity in the brain, which leads to that are in some cases fatal.

Explore further: Could cannabis-derived medicine help type 2 diabetes sufferers?

More information: Reference: Hill AJ, Mercier MS, Hill TDM, Glyn SE, Jones NA, Yamasaki Y et al. (2012) Cannabidivarin is anticonvulsant in mouse and rat in vitro and in seizure models.  Br J Pharmacol doi.wiley.com/10.1111/j.1476-5381.2012.02207.x

Related Stories

Recommended for you

Scientists identify neurons devoted to social memory

September 30, 2016

Mice have brain cells that are dedicated to storing memories of other mice, according to a new study from MIT neuroscientists. These cells, found in a region of the hippocampus known as the ventral CA1, store "social memories" ...

Throwing light on the brain's perception of transparency

September 30, 2016

Researchers have created a new optical illusion that helps reveal how our brains determine the material properties of objects – such as whether they are transparent, shiny, matte or translucent – just from looking at ...

Scientists track unexpected mechanisms of memory

September 29, 2016

Do you remember Simone Biles's epic gymnastics floor routine that earned her a fifth Olympic medal? Our brains hold on to memories like these via physical changes in synapses, the tiny connections between neurons.

Some brains are blind to moving objects

September 28, 2016

As many as half of people are blind to motion in some part of their field of vision, but the deficit doesn't have anything to do with the eyes.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Shootist
3 / 5 (2) Sep 13, 2012
Cannabis. Like bacon, is there nothing it cannot do?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.